
Oruka Therapeutics Inc (ORKA)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -51.225 | -99.962 | -82.678 | -71.376 | -33.03 | -36.68 | -20.255 | -13.192 |
Return on Equity (%) | -54.573 | -113.893 | -97.296 | -80.369 | -35.979 | -39.609 | -21.412 | -13.569 |
Return on Invested Capital (%) | -58.79 | -127.193 | -99.477 | -83.081 | -36.074 | -39.648 | -22.866 | -18.55 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 2.444 | 0.873 | 0.433 | 4.774 | 4.872 | 3.542 | 2.892 | 2.569 |
Earnings Per Share | -1.811 | -1.57 | -0.57 | -3.439 | -1.02 | -1.341 | -0.689 | -0.371 |
Cash Per Share | 0.815 | 0.739 | 0.475 | 5.247 | 5.139 | 3.703 | 2.946 | 2.598 |
Working Capital Per Share | 2.097 | 0.869 | 0.43 | 4.739 | 4.867 | 3.534 | 2.885 | 2.565 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -1.811 | -1.575 | -0.572 | -3.544 | -1.021 | -1.341 | -0.689 | -0.371 |
EBITDA Per Share | -1.811 | -1.575 | -0.572 | -3.544 | -1.021 | -1.341 | -0.689 | -0.371 |
Free Cash Flow Per Share | -1.812 | -1.572 | -0.571 | -3.448 | -1.019 | -1.339 | -0.69 | -0.372 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 9,08M | 11,78M | 13,92M | 1,59M | 9,55M | 14,41M | 14,41M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 14,41M | 14,41M | N/A | N/A | 14,41M | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 368,53M |
Ratio cours/bénéfice | -70,23 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 10,01 |
Ratio prix/valeur comptable | 10,13 |
Rendement de dividende | - |
Actions en circulation | 35M |
Volume moyen (1 semaine) | 198,8k |
Volume moyen (1 mois) | 262,34k |
Variation sur 52 semaines | -63,72% |
Plus haut sur 52 semaines | 31,13 |
Plus bas sur 52 semaines | 10,26 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales